1-800-PetMeds (NASDAQ:PETS) to go ex-dividend.On 5/7/2018 1-800-PetMeds ( NASDAQ:PETS ) announced that it will be issuing a quarterly dividend in the amount of $0.25 down from $0.25 making the yield 2.92%.1-800-PetMeds (NASDAQ:PETS) Ex- dividend date1-800-PetMeds (NASDAQ:PETS) is set to go ex-dividend on and will be payable on 5/25/2018 Dividend History for 1-800-PetMeds (NASDAQ:PETS) The next payable dividend for 1-800-PetMeds is scheduled for 5/25/2018. There is an annual dividend of $$1.00 with a yield of 2.83% The payout ration for the trailing 12 months of earnings is 85.47% , 56.50% based on this years estimates and 46.51% based on next years projected estimates.Recent Dividend History for 1-800-PetMeds (NASDAQ:PETS)
- On 1/28/2013 1-800-PetMeds announced a quarterly dividend of $0.15.
- On 5/3/2013 1-800-PetMeds announced a quarterly dividend of $0.15.
- On 7/26/2013 1-800-PetMeds announced a quarterly dividend of $0.17.
- On 10/28/2013 1-800-PetMeds announced a quarterly dividend of $0.17.
- On 1/30/2014 1-800-PetMeds announced a quarterly dividend of $0.17.
- On 5/5/2014 1-800-PetMeds announced a quarterly dividend of $0.17.
Recent Insider Trading for 1-800-PetMeds (NASDAQ:PETS)
- On 1/29/2018 Ronald J Korn, Director, sold 5,000 with an average share price of $48.38 per share and the total transaction amounting to $241,900.00.
- On 1/22/2018 Menderes Akdag, CEO, sold 10,000 with an average share price of $57.00 per share and the total transaction amounting to $570,000.00.
- On 1/11/2018 Menderes Akdag, CEO, sold 30,000 with an average share price of $51.00 per share and the total transaction amounting to $1,530,000.00.
- On 12/15/2017 Gian Fulgoni, Director, sold 20,000 with an average share price of $44.38 per share and the total transaction amounting to $887,600.00.
- On 10/27/2017 Ronald J Korn, Director, sold 1,000 with an average share price of $35.57 per share and the total transaction amounting to $35,570.00.
- On 8/1/2017 Robert C Schweitzer, Director, sold 2,500 with an average share price of $49.18 per share and the total transaction amounting to $122,950.00.
Recent Analyst Rating for 1-800-PetMeds (NASDAQ:PETS)
- On 1/3/2018 Northcoast Research, Set Price Target, to bought with a price target of $58.00
- On 10/27/2017 Noble Financial, Reiterated Rating, to Hold
- On 10/2/2017 Credit Suisse Group, Reiterated Rating, to Underperform with a price target of $19.00
- On 8/24/2017 Sidoti, Upgrade, to Neutral ➝ Buy with a price target of $47.00
- On 8/21/2017 Craig Hallum, Reiterated Rating, to Hold with a price target of $43.00 ➝ $40.00
Recent Trading for 1-800-PetMeds (NASDAQ:PETS) Shares of 1-800-PetMeds closed the previous trading session at 35.04 up +0.74 2.16% with 1040878 shares trading hands.